Wednesday, 30 September 2026Updated 12m ago
← Top stories
● Neutral for Indian equities

Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

1 source · first seen 19:45 30 Sept · updated 19:45 30 Sept

The brief

Written from 1 report · check the source before you trade
  • Eli Lilly plans Phase 3 trials by year-end for eloralintide combined with tirzepatide

Tags on this story

Pick a tag to see all its stories

Linked by the tag Eli Lilly

11 stories this week
  1. 28 SeptKerala HC says government can intervene over exorbitant prices of patented drugsLegal · 3 sources · The Kerala High Court ruled government intervention is permissible for prohibitively priced patented medicines
All Eli Lilly stories →

Read the reports

1 report · earliest 19:45
CNBCEli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial19:45